Tuesday June 21, 2022
Ophthalmology
Ophthalmology continues to be a big area of investor interest with considerable scope for consolidation. Governments are increasingly outsourcing cataract operations and the sector is starting to unlock the potential for multifocal lens in middle age. We’ll explore how businesses are increasing their value in the drive for profit growth.
Speakers include:
Tim Clover, CEO, Rayner
Peter Byloos, CEO, Optegra
Ulla Napankangas, CEO, Coronaria Eye Health
Moderated by: Tobias Koesters, Partner, L.E.K. Consulting








St James - 4th Floor
Explore similar sessions
2022 Health Care M&A Landscape
2021 has been a record year for deal activity and IPOs. But as multiples hit a ceiling, what will happen in 2022? Investors are keeping a watchful eye on inflation,...
Fleming - 3rd Floor


Mental Health
Covid has created huge extra demand for mental health services. How far can this be met by digital therapeutics and how can operators consolidate this fragmented sector? And how far...
Whittle - 3rd Floor









Primary Care PLUS
The huge primary care sector in Europe holds the key to outpatient consolidation. Here we look at how operators are pairing it with digital and telehealth, pharmacies and imaging. And...
Whittle - 3rd Floor








